Menu

Speaking of Science

May 2015's selection of notable quotes

May 1, 2015
The Scientist Staff

© ISTOCK.COM/JGROUP

A fatal disease has been tamed into a chronic condition. The next step is to find a cure. Scientists are innately cautious, and AIDS researchers have learned humility over the years. Science operates around a core of uncertainty, within which lie setbacks, but also hope.

—Harvard Medical School researcher Jerome Groopman, in a New Yorker article about the quest to find a cure for AIDS (December 22 & 29, 2014)

 

For a long time scientists were cautious about referring to a cure. The possibility just seemed so out of reach. But people are talking about it more now than they used to. Several drug companies are shifting away from developing new HIV drugs to pursuing strategies for using existing drugs to eradicate the virus. 

Robert Siliciano, Johns Hopkins University infectious disease researcher who studies HIV latency, on the website of the university’s Institute for Basic Biomedical Sciences

 

The currency of science is fragile, and allowing counterfeiters, fraudsters, bunko artists, scammers, and cheats to continue to operate with abandon in the publishing realm is unacceptable.

—New York University bioethicist Arthur Caplan, in a Mayo Clinic Proceedings commentary about problems in science publishing (April 3)

 

I think we’re going to have strong indications of life beyond Earth within a decade, and I think we’re going to have definitive evidence within 20 to 30 years.

Ellen Stofan, NASA chief scientist, speaking during a recent NASA panel discussion about the search for water in the universe (April 7)

 

As HIV investigators continue the campaign to control and conceivably eradicate HIV worldwide, certain directions reflecting myths or misconceptions about this infectious disease have been embraced, while other concepts with merit have been left relatively unexplored. These issues in HIV pathogenesis threaten to prevent a true long-term solution to HIV infection and, perhaps, infections by other human pathogens. 

—Prominent HIV researcher Jay Levy of the University of California, San Francisco, in a recently published opinion article about HIV research (Trends in Molecular Medicine, April 14)

 

Most work going on in brain imaging is of no scientific value.

Margaret Boden, cognitive scientist at the University of Sussex, U.K., speaking with New Scientist about understanding human consciousness (March 31)

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.